Jane Street
FLNA

Jane Street’s Filana Therapeutics FLNA Stock Holding History

Jane Street’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.5K Sell
61,800
-20,500
-25% -$29.2K ﹤0.01% 10765
2026
Q1 		$139K Sell
82,300
-14,600
-15% -$30.1K ﹤0.01% 10448
2025
Q4 		$192K Sell
96,900
-300
-0.3% -$960 ﹤0.01% 9759
2025
Q3 		$283K Buy
97,200
+52,800
+119% +$121K ﹤0.01% 9024
2025
Q2 		$80.4K Sell
44,400
-65,300
-60% -$116K ﹤0.01% 9048
2025
Q1 		$165K Sell
109,700
-290,800
-73% -$734K ﹤0.01% 8581
2024
Q4 		$945K Buy
400,500
+89,900
+29% +$1.58M ﹤0.01% 5501
2024
Q3 		$9.14M Buy
310,600
+274,000
+749% +$6.31M ﹤0.01% 1999
2024
Q2 		$452K Sell
36,600
-34,400
-48% -$725K ﹤0.01% 7187
2024
Q1 		$1.43M Sell
71,000
-234,500
-77% -$5.4M ﹤0.01% 4740
2023
Q4 		$7.02M Buy
305,500
+135,700
+80% +$2.87M ﹤0.01% 2386
2023
Q3 		$2.83M Buy
169,800
+70,000
+70% +$1.39M ﹤0.01% 3462
2023
Q2 		$2.45M Sell
99,800
-91,400
-48% -$2.2M ﹤0.01% 3855
2023
Q1 		$4.61M Sell
191,200
-112,900
-37% -$3.13M ﹤0.01% 2571
2022
Q4 		$8.98M Sell
304,100
-269,900
-47% -$9.7M ﹤0.01% 1742
2022
Q3 		$24M Buy
574,000
+265,600
+86% +$7.17M 0.01% 924
2022
Q2 		$8.67M Buy
308,400
+33,400
+12% +$844K ﹤0.01% 1915
2022
Q1 		$10.2M Sell
275,000
-404,000
-59% -$17.1M ﹤0.01% 1963
2021
Q4 		$29.7M Sell
679,000
-520,300
-43% -$27.3M 0.01% 925
2021
Q3 		$74.5M Buy
1,199,300
+801,400
+201% +$66.9M 0.03% 439
2021
Q2 		$34M Buy
397,900
+23,800
+6% +$1.27M 0.01% 740
2021
Q1 		$16.8M Buy
374,100
+351,100
+1,527% +$13.8M 0.01% 1121
2020
Q4 		$157K Sell
23,000
-176,300
-88% -$1.57M ﹤0.01% 7061
2020
Q3 		$2.29M Buy
+199,300
New +$898K ﹤0.01% 2829

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Jane Street's FLNA Position: Q2 2026 in Review

Jane Street reduced its Filana Therapeutics (FLNA) stake by 74% in Q2 2026, selling an estimated $237K and leaving 58,981 shares worth $70.2K. The position accounts for ﹤0.01% of the portfolio, ranked #10785.

Jane Street first reported a position in FLNA in Q2 2013 and has held it in 32 quarters since. The position peaked at $14.9M in Q2 2021. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Jane Street held 58,981 shares of Filana Therapeutics worth $70.2K as of Q2 2026.
  • Jane Street sold 166,183 Filana Therapeutics shares in Q2 2026, an estimated $237K.
  • Filana Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10785 holding.
  • Jane Street first reported a position in Filana Therapeutics in Q2 2013 and has held it in 32 quarters since.
  • Jane Street's Filana Therapeutics position peaked at $14.9M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.